Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer
Clinical trial NCT06835725 · RECRUITING
Trial details
- NCT number
- NCT06835725
- Sponsor
- British Columbia Cancer Agency
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-04
- Primary completion
- 2032-04-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.